Skip to main content

Advertisement

Log in

Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The pathophysiology of non-traumatic osteonecrosis is more complex than that of traumatic osteonecrosis, and corticosteroid-induced osteonecrosis presents the greatest challenge because of the multiple effects of corticosteroids on multi-system pathways; these pathways include the effects of corticosteroids on osteoblast differentiation, osteoblast and osteoclast apoptosis, lipid metabolism, coagulation pathways, and calcium metabolism. These pathways are frequently interrelated with each other, which makes the pathogenesis even more difficult to understand. Host factors and underlying disease have been shown to play a significant role in the risk of developing osteonecrosis, and our understanding of the pathogenesis must be able to explain why some patients are at greater risk than others. Identification of genetic variants that convey additional risk will also help to personalize the way we deliver care, both in the prevention and treatment of osteonecrosis. Further understanding of the intricate immunologic and genetic pathways contributing to osteonecrosis is at the forefront of research and may soon lead to viable and less invasive non-surgical therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME (2010) Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 9:721–743

    Article  PubMed  CAS  Google Scholar 

  2. Chang C, Greenspan A, Gershwin ME. Osteonecrosis. In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS (2009) Textbook of Rheumatology, 8th Edition, Saunders, Philadelphia, pp 1611–1628

  3. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124

    PubMed  Google Scholar 

  4. Spencer JD, Brookes M (1988) Avascular necrosis and the blood supply of the femoral head. Clin Orthop Relat Res 235:127–140

    PubMed  Google Scholar 

  5. Jacobs B (1978) Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 130:51–67

    PubMed  Google Scholar 

  6. Atsumi T, Kuroki Y (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 277:22–30

    PubMed  Google Scholar 

  7. Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783–791

    PubMed  CAS  Google Scholar 

  8. Jones JP Jr (1999) Coagulopathies and osteonecrosis. Acta Orthop Belg 65(Suppl 1):5–8

    PubMed  Google Scholar 

  9. Chandler FA (1948) Coronary disease of the hip. J Int Coll Surg 11:34–36

    PubMed  CAS  Google Scholar 

  10. Chandler FA (1949) Coronary disease of the hip. Clin Orthop Relat Res 2001:7–10

    Google Scholar 

  11. Silvestrini G, Mocetti P, Ballanti P, Di Grezia R, Bonucci E (1999) Cytochemical demonstration of the glucocorticoid receptor in skeletal cells of the rat. Endocr Res 25:117–128

    PubMed  CAS  Google Scholar 

  12. Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T (1997) Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397–406

    Article  PubMed  CAS  Google Scholar 

  13. Liesegang P, Romalo G, Sudmann M, Wolf L, Schweikert HU (1994) Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha, 25-dihydroxycholecalciferol receptors. J Androl 15:194–199

    PubMed  CAS  Google Scholar 

  14. Yoshioka T, Sato B, Matsumoto K, Ono K (1980) Steroid receptors in osteoblasts. Clin Orthop Relat Res 148:297–303

    PubMed  CAS  Google Scholar 

  15. Kerachian MA, Seguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128

    Article  PubMed  CAS  Google Scholar 

  16. Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis—a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213

    Article  PubMed  CAS  Google Scholar 

  17. Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85:2907–2912

    Article  PubMed  CAS  Google Scholar 

  18. Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B (2004) Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci 75:2879–2895

    Article  PubMed  CAS  Google Scholar 

  19. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL et al (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041–1048

    PubMed  CAS  Google Scholar 

  20. Kawai K, Tamaki A, Hirohata K (1985) Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J Bone Joint Surg Am 67:755–763

    PubMed  CAS  Google Scholar 

  21. Boskey AL, Raggio CL, Bullough PG, Kinnett JG (1983) Changes in the bone tissue lipids in persons with steroid- and alcohol-induced osteonecrosis. Clin Orthop Relat Res 172:289–295

    PubMed  Google Scholar 

  22. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282

    Article  PubMed  CAS  Google Scholar 

  23. Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis Clin Orthop Relat Res 370:295–310

    Google Scholar 

  24. Aspenberg P (2006) Osteonecrosis of the jaw: what do bisphosphonates do? Expert Opin Drug Saf 5:743–745

    Article  PubMed  CAS  Google Scholar 

  25. Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43

    Article  PubMed  Google Scholar 

  26. Bilezikian JP (2006) Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 355:2278–2281

    Article  PubMed  CAS  Google Scholar 

  27. Pendrys DG, Silverman SL (2008) Osteonecrosis of the jaws and bisphosphonates. Curr Osteoporos Rep 6:31–38

    Article  PubMed  Google Scholar 

  28. Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis 2010 (In press)

  29. Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM (1978) Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res 16:369–372

    Article  PubMed  CAS  Google Scholar 

  30. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244

    Article  PubMed  Google Scholar 

  31. Feng Y, Yang SH, Xiao BJ, et al (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46:32–40

    Google Scholar 

  32. Li YM, Wang SX, Gao HS, Wang JG, Wei CS, Chen LM, Hui WL et al (2004) Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence. Zhonghua Yi Xue Za Zhi 84:1348–1353

    PubMed  Google Scholar 

  33. Jones JP Jr, Ramirez S, Doty SB (1993) The pathophysiologic role of fat in dysbaric osteonecrosis. Clin Orthop Relat Res 296:256–264

    PubMed  Google Scholar 

  34. Gray E, Thomas S, Mistry Y, Poole S (1996) Inhibition of tissue factor and cytokine release. Haemostasis 26(Suppl 1):92–95

    PubMed  CAS  Google Scholar 

  35. van Giezen JJ, Jansen JW (1992) Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone. Ann NY Acad Sci 667:199–201

    Article  PubMed  Google Scholar 

  36. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47–56

    PubMed  CAS  Google Scholar 

  37. Boss JH, Misselevich I (2003) Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 40:345–354

    Article  PubMed  CAS  Google Scholar 

  38. Hirata T, Fujioka M, Takahashi KA, Asano T, Ishida M, Akioka K, Okamoto M et al (2007) Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant. J Rheumatol 34:516–522

    PubMed  CAS  Google Scholar 

  39. Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP et al (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74:1147–1152

    Article  PubMed  CAS  Google Scholar 

  40. Kang P, Shen B, Yang J, Pei F (2008) Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res 123:367–373

    Article  PubMed  CAS  Google Scholar 

  41. Chotanaphuti T, Heebthamai D, Chuwong M, Kanchanaroek K (2009) The prevalence of thrombophilia in idiopathic osteonecrosis of the hip. J Med Assoc Thai 92(Suppl 6):S141–S146

    PubMed  Google Scholar 

  42. Glueck CJ, Freiberg RA, Boppana S, Wang P (2008) Thrombophilia, hypofibrinolysis, the eNOS T-786 C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am 90:2220–2229

    Article  PubMed  Google Scholar 

  43. Glueck CJ, Freiberg RA, Wang P (2008) Heritable thrombophilia–hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res 466:1034–1040

    Article  PubMed  Google Scholar 

  44. Seguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ (2008) Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 47:1151–1155

    Article  CAS  Google Scholar 

  45. Arlet J, Ficat P, Lartigue G, Tran MA (1972) Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis. Rev Rhum Mal Osteo-artic 39:717–723

    CAS  Google Scholar 

  46. Wang KZ, Mao LZ, Hu CG (1994) Experimental study on mechanism of steroid-induced avascular necrosis of femoral head. Zhonghua Wai Ke Za Zhi 32:515–517

    PubMed  CAS  Google Scholar 

  47. Wang KZ, Wang CS, Wu YG, Chen H (2006) Changes of vessel in steroid-induced osteonecrosis of femoral head: experimental study of rabbits. Zhonghua Yi Xue Za Zhi 86:2024–2027

    PubMed  CAS  Google Scholar 

  48. Wang ZX, Yang ZX (1985) Experimental observations on the biological features and pathogenicity of Thelazia callipaeda parasitized in rabbits. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 3:128–130

    PubMed  CAS  Google Scholar 

  49. Welch RD, Johnston CE 2nd, Waldron MJ, Poteet B (1993) Bone changes associated with intraosseous hypertension in the caprine tibia. J Bone Joint Surg Am 75:53–60

    PubMed  CAS  Google Scholar 

  50. Saito S, Ohzono K, Ono K (1992) Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles Clin Orthop Relat Res 277:98–110

    Google Scholar 

  51. Yang C, Yang S, Du J, Li J, Xu W, Xiong Y (2003) Experimental study of vascular endothelial growth factor gene therapy for avascular necrosis of the femoral head. J Huazhong Univ Sci Technolog Med Sci 23(297–299):316

    Google Scholar 

  52. Li X, Jin L, Cui Q, Wang GJ, Balian G (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16:101–108

    Article  PubMed  Google Scholar 

  53. Harada I (1992) The effects of glucocorticoids on angiogenesis in vitro. Nippon Seikeigeka Gakkai Zasshi 66:763–770

    PubMed  CAS  Google Scholar 

  54. Wolff JE, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9 L rat brain tumors. Brain Res 604:79–85

    Article  PubMed  CAS  Google Scholar 

  55. Boss JH (2004) Experimental models of osteonecrosis of the femoral head. J Orthop Sci 9:533–534

    Article  PubMed  Google Scholar 

  56. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 9:509–515

    Article  PubMed  CAS  Google Scholar 

  57. Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44:456–460

    Article  CAS  Google Scholar 

  58. Ichiseki T, Matsumoto T (2006) Oxidative stress may underlie the sex differences seen in steroid-induced osteonecrosis models. Med Hypotheses 66:1256

    Article  PubMed  CAS  Google Scholar 

  59. Jaffe WL, Epstein M, Heyman N, Mankin HJ (1972) The effect of cortisone on femoral and humeral heads in rabbits. An experimental study. Clin Orthop Relat Res 82:221–228

    Article  PubMed  CAS  Google Scholar 

  60. Zhou Q, Li Q, Yang L, Liu F (2000) Changes of blood vessels in glucocorticoid-induced avascular necrosis of femoral head in rabbits. Zhonghua Wai Ke Za Zhi 38(212–215):213

    Google Scholar 

  61. Chen XC, Weng J, Chen XQ, Du JZ, Zhu MP, Pan YQ, Liu M (2008) Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits. J Zhejiang Univ Sci B 9:739–746

    Article  PubMed  CAS  Google Scholar 

  62. Cui Q, Wang GJ, Su CC, Balian G (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis Clin Orthop Relat Res 344:8–19

    Google Scholar 

  63. Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC (1978) Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res 130:81–85

    PubMed  CAS  Google Scholar 

  64. Jones JP Jr (1985) Fat embolism and osteonecrosis. Orthop Clin North Am 16:595–633

    PubMed  Google Scholar 

  65. Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y (2008) Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 35:2395–2399

    Article  PubMed  CAS  Google Scholar 

  66. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50:3387–3391

    Article  PubMed  CAS  Google Scholar 

  67. Yamamoto T, Irisa T, Sugioka Y, Sueishi K (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 40:2055–2064

    Article  PubMed  CAS  Google Scholar 

  68. Motomura G, Yamamoto T, Miyanishi K, Kondo K, Hirota Y, Iwamoto Y (2008) Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol 35:2391–2394

    Article  PubMed  Google Scholar 

  69. Tokuhara Y, Wakitani S, Oda Y, Kaneshiro Y, Masada T, Kim M, Kadoya Y et al (2009) Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci 14:794–800

    Article  PubMed  CAS  Google Scholar 

  70. Masada T, Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Ohashi H, Takaoka K (2008) Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 26:91–95

    Article  PubMed  CAS  Google Scholar 

  71. Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K et al (2006) Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther 80:396–402

    Article  PubMed  CAS  Google Scholar 

  72. Asano T, Takahashi KA, Fujioka M, Inoue S, Satomi Y, Nishino H, Tanaka T et al (2003) Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci 8:329–333

    Article  PubMed  CAS  Google Scholar 

  73. Wang XY, Niu XH, Chen WH, Lin N, Song JN, Chen B, Jin H (2008) Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. Zhongguo Gu Shang 21:99–102

    PubMed  Google Scholar 

  74. Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M et al (2004) Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77:220–225

    Article  PubMed  Google Scholar 

  75. Kim TH, Hong JM, Shin ES, Kim HJ, Cho YS, Lee JY, Lee SH et al (2009) Polymorphisms in the annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population. Bone 45:125–131

    Article  PubMed  CAS  Google Scholar 

  76. Kim TH, Hong JM, Oh B, Cho YS, Lee JY, Kim HL, Lee JE et al (2008) Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Exp Mol Med 40:418–426

    Article  PubMed  CAS  Google Scholar 

  77. Kenzora JE (1983) Ischemic necrosis of femoral head. Part I. Accumulative cell stress: a hypothesis for the etiology of idiopathic osteonecrosis. Instr Course Lect 32:242–252

    PubMed  CAS  Google Scholar 

  78. Kenzora JE (1985) Treatment of idiopathic osteonecrosis: the current philosophy and rationale. Orthop Clin North Am 16:717–725

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Eric Gershwin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Powell, C., Chang, C. & Gershwin, M.E. Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis. Clinic Rev Allerg Immunol 41, 102–113 (2011). https://doi.org/10.1007/s12016-010-8217-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-010-8217-z

Keywords

Navigation